Showing results (641-650 of 674) with videos related to

Sort By:
Pageof 68
AJNR. American Journal of Neuroradiology|March 4, 2008
Intracranial stenting of severe symptomatic intracranial stenosis: results of 100 consecutive patientsD C Suh, J K Kim, J W Choi, et al.
Clinical Pharmacology and Therapeutics|July 29, 2010
Pharmacokinetics of oltipraz and its major metabolite (RM) in patients with liver fibrosis or cirrhosis: relationship with suppression of circulating TGF-beta1S G Kim, Y M Kim, Y H Choi, et al.
FEBS Letters|July 14, 1998
Molecular cloning of a novel GTP-binding protein induced in fish cells by rhabdovirus infectionE H Lee, H J Kim, J J Park, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 3, 2020
Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trialM Schuler, R Berardi, W-T Lim, et al.
Stroke|June 10, 2006
Identification of penumbra and infarct in acute ischemic stroke using computed tomography perfusion-derived blood flow and blood volume measurementsB D Murphy, A J Fox, D H Lee, et al.
Scientific Reports|February 19, 2016
Magnetic effects in sulfur-decorated grapheneChoongyu Hwang, Shane A Cybart, S J Shin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 4, 2012
The influence of hospital volume and surgical treatment delay on long-term survival after cancer surgeryY H Yun, Y A Kim, Y H Min, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2021
First-in-human phase 1 study of the anti-TIGIT antibody vibostolimab as monotherapy or with pembrolizumab for advanced solid tumors, including non-small-cell lung cancer<sup>☆</sup>J Niu, C Maurice-Dror, D H Lee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 4, 2020
Safety and efficacy of quavonlimab, a novel anti-CTLA-4 antibody (MK-1308), in combination with pembrolizumab in first-line advanced non-small-cell lung cancerR Perets, J Bar, D W Rasco, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 18, 2013
Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancerJ-M Sun, Y C Ahn, E K Choi, et al.
Pageof 68